ImmunoBiochem Corporation
- Biotech or pharma, therapeutic R&D
ImmunoBiochem is a pharma-partnered biotech developing novel antibody conjugate modalities:
- tumor microenvironment-targeted bioconjugates (ADCs and DACs) against heterogeneous solid tumors via targets amplified in the cancer cell secretomes
- protein degrader-based antibody conjugates (DACs) for precision immunology
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}